FDA DEVICE FACTS
ETEST Gepotidacin (GEP) (0.016-256 µg/mL)
bioMérieux SA
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
ETEST is a manual, quantitative technique for the determination of antimicrobial susceptibility of non‑fastidious Gram‑negative and Gram‑positive aerobic bacteria and fastidious bacteria. The system comprises a predefined antibiotic gradient which is used to determine the Minimum Inhibitory Concentration (MIC, in μg/mL) of different antimicrobial agents against microorganisms tested on agar media after overnight incubation. Testing with ETEST Gepotidacin (GEP) (0.016-256 μg/mL) is indicated for Enterobacterales, Staphylococcus saprophyticus, Enterococcus faecalis and Neisseria gonorrhoeae, as recognized by the FDA Susceptibility Test Interpretive Criteria (STIC). ETEST Gepotidacin (GEP) (0.016-256 μg/mL) demonstrated acceptable performance with the following microorganisms:
• Escherichia coli
• Staphylococcus saprophyticus
• Enterococcus faecalis
• Neisseria gonorrhoeae
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。